Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial

Authors

Institutions

Publication Details

Journal
AIDS
Published
2026-03-03
DOI
https://doi.org/10.1097/qad.0000000000004476
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial

Phyo Pyae Nyein, Dianne Carey, K Petoumenos, Josh Hanson et al.
AIDS
HIV-related health complications and treatments
article

Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial

Phyo Pyae Nyein, Dianne Carey, K Petoumenos, Josh Hanson, M. A. Kundro, Blessing Uche, R Kaplan, Gail V Matthews, Dannae Brown
article en

Abstract

No abstract available for this paper.
AIDS
The University of Sydney (AU), Desmond Tutu HIV Foundation (ZA), University of Cape Town (ZA), UNSW Sydney (AU), Hospital Ramos Mejía (AR), Institute of Human Virology (NG)
Gender equality
Openalex Percentile: Top 37%
HIV-related health complications and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.